Get the Stockscreener App
1.15
0.00%
0.00
Pre-market:
1.14
-0.01
-0.87%
Equillium Inc stock is traded at $1.15, with a volume of 439.91K.
It is up +0.00% in the last 24 hours and up +0.00% over the past month.
Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its product candidates either independently or through partnerships, or otherwise monetize its pipeline through strategic transactions. Itolizumab (EQ001), a clinical-stage product candidate, is an anti-CD6 immune-modifying monoclonal antibody, or mAb, that selectively targets the CD6-ALCAM signaling pathway to downregulate pathogenic T effector cells while preserving T regulatory cells critical for maintaining a balanced immune response. The company's other clinical-stage and pre-clinical-stage candidates include EQ101 and EQ302.
See More
Previous Close:
$1.15
Open:
$1.12
24h Volume:
439.91K
Relative Volume:
0.67
Market Cap:
$70.03M
Revenue:
$45.91M
Net Income/Loss:
$-4.62M
P/E Ratio:
-8.2026
EPS:
-0.1402
Net Cash Flow:
$-21.51M
1W Performance:
+4.55%
1M Performance:
+0.00%
6M Performance:
+177.04%
1Y Performance:
+78.60%
1-Day Range:
$1.11
$1.1752
1-Week Range:
$1.05
$1.22
52-Week Range:
$0.27
$2.35
Equillium Inc Stock (EQ) Company Profile
Name
Equillium Inc
Sector
Industry
Phone
(858) 412-5302
Address
2223 AVENIDA DE LA PLAYA, LA JOLLA, CA
Compare EQ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EQ
Equillium Inc
|
1.15 | 70.03M | 45.91M | -4.62M | -21.51M | -0.1402 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.08 | 111.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.78 | 77.04B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
809.64 | 49.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
355.53 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
334.28 | 37.42B | 4.98B | 69.59M | 525.67M | 0.5197 |
Equillium Inc Stock (EQ) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-28-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Oct-29-21 | Resumed | Stifel | Buy |
| Sep-15-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-14-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-10-20 | Resumed | Stifel | Buy |
| Feb-22-19 | Initiated | SVB Leerink | Outperform |
View All
Equillium Inc Stock (EQ) Latest News
Market Leaders: What is the target price for Equillium Inc stock2025 Trade Ideas & Expert Curated Trade Setups - baoquankhu1.vn
Aug Technicals: Can Equillium Inc reach all time highs this yearBond Market & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Market Outlook: Is Equillium Inc stock a buy before product launchesIndex Update & Technical Pattern Recognition Alerts - Bộ Nội Vụ
Does Equillium Inc stock have upside surprise potentialTrade Risk Report & Long-Term Safe Investment Ideas - baoquankhu1.vn
Reviewing Mineralys Therapeutics (NASDAQ:MLYS) and Equillium (NASDAQ:EQ) - Defense World
Will Equillium Inc. stock reach all time highs in 2025Market Trend Report & Accurate Buy Signal Notifications - Улправда
Equillium principal accounting officer Tom Penny sells $8427 in stock By Investing.com - Investing.com South Africa
Equillium principal accounting officer Tom Penny sells $8427 in stock - Investing.com
Why Equillium Inc. stock is favored by top institutionsJuly 2025 Trends & Weekly Consistent Profit Watchlists - Улправда
Will Equillium Inc. stock benefit from sector rotationJuly 2025 Rallies & Low Volatility Stock Recommendations - Улправда
Is Equillium Inc. stock a top pick in earnings seasonWeekly Market Report & Fast Entry Momentum Alerts - Улправда
Can Equillium Inc. stock double in next 5 yearsEarnings Summary Report & Low Risk High Reward Trade Ideas - Улправда
Equillium, Inc. (NASDAQ:EQ) Short Interest Up 22.7% in December - MarketBeat
Equillium (NASDAQ:EQ) COO Christine Zedelmayer Sells 100,000 Shares - MarketBeat
Can Equillium Inc. stock sustain free cash flow growthPortfolio Return Report & Fast Moving Market Watchlists - Улправда
Is Equillium Inc. (0FY) stock trading at attractive multiplesQuarterly Risk Review & Consistent Profit Focused Trading Strategies - bolumsonucanavari.com
Will Equillium Inc. (0FY) stock maintain strong growthWeekly Trading Summary & Fast Momentum Entry Tips - DonanımHaber
Aug Wrap: Can Equillium Inc. stock sustain free cash flow growthEarnings Trend Report & Low Risk High Win Rate Picks - Улправда
Christine Zedelmayer Sells 11,900 Shares of Equillium (NASDAQ:EQ) Stock - MarketBeat
Christine Zedelmayer Sells 23,804 Shares of Equillium (NASDAQ:EQ) Stock - MarketBeat
Insider Sell: Christine Zedelmayer Sells 35,704 Shares of Equill - GuruFocus
COO Zedelmayer Sells 35,704 ($47.5K) Of Equillium Inc [EQ] - TradingView — Track All Markets
Equillium Senior VP and COO Christine Zedelmayer Sells Shares - TradingView — Track All Markets
JANUS HENDERSON GROUP PLC Acquires Significant Stake in Equilliu - GuruFocus
What is Equillium Inc (EQ) Stock Return on Shareholders’ Capital? - setenews.com
EQ FinancialsIncome Statement - Quiver Quantitative
EQ Insider Trading - Quiver Quantitative
Top Pre‑Market Gainers Today, December 10, 2025: ASPC, ENVB, BDRX and APVO Lead Fed‑Day Frenzy - TechStock²
Equillium (NASDAQ:EQ) Stock Price Up 2.6% – Should You Buy? - Defense World
Equillium (NASDAQ:EQ) Stock Price Up 2.6%Should You Buy? - MarketBeat
Can Equillium Inc 0FY stock attract analyst upgrades2025 Earnings Impact & Weekly Return Optimization Alerts - moha.gov.vn
Will Equillium Inc. stock deliver shareholder value2025 Market Sentiment & Weekly High Return Opportunities - Newser
Why Equillium Inc. (0FY) stock could rally stronglyEarnings Overview Summary & Low Risk High Reward Ideas - Newser
Can Equillium Inc. (0FY) stock survive global slowdownTrend Reversal & Consistent Growth Stock Picks - Newser
Can Equillium Inc. stock maintain growth trajectory2025 Big Picture & Growth Oriented Trade Recommendations - Newser
Equillium Inc (EQ) can make a big difference with a little luck - setenews.com
Will Equillium Inc. (0FY) stock outperform small cap peersJuly 2025 Short Interest & Weekly High Conviction Trade Ideas - Newser
How Equillium Inc. (0FY) stock expands through international marketsJuly 2025 Retail & Daily Chart Pattern Signals - Newser
What technical patterns form on Equillium Inc. (0FY) stock chartsEarnings Growth Report & Long-Term Growth Portfolio Plans - Newser
What hedge fund activity signals for Equillium Inc. stockJuly 2025 Sector Moves & Short-Term High Return Ideas - Newser
EQ SEC FilingsEquillium 10-K, 10-Q, 8-K Forms - Stock Titan
Will Equillium Inc. (0FY) stock outperform global peersGold Moves & Verified Momentum Stock Alerts - Newser
Is Equillium Inc. (0FY) stock at risk of policy regulationJobs Report & Technical Pattern Based Buy Signals - Newser
Can Equillium Inc. (0FY) stock attract analyst upgradesEarnings Recap Report & Verified Chart Pattern Signals - Newser
Market Fear: Can Equillium Inc. stock sustain free cash flow growthJuly 2025 Drop Watch & Technical Buy Zone Confirmation - BỘ NỘI VỤ
Equillium Inc. (EQ) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Equillium, Inc. (0A4D.L) Stock Price, News, Quote & History - Yahoo! Finance Canada
Equillium SVP Zedelmayer sells $7.7k in stock By Investing.com - Investing.com Nigeria
Equillium Inc Stock (EQ) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.85%
1.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):